DTIL PRECISION BIOSCIENCES INC
Nasdaq · SEC CIK 1357874 · EDGAR
- Bought, last 12 months
- $47.1K 4 purchases by 3 insiders
- Sold, last 12 months
- $466.2K 11 sales by 4 insiders
- Filings on record
- 162 since 2021-10-19, latest 2026-06-05 07:39
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Amoroso Michael | Pres, CEO, Dir | — | $246.2K |
| Kelly John Alexander | CFO | — | $101.1K |
| SMITH J. JEFFERSON | Chief Research Off | — | $60.0K |
| Scimeca Dario | GC, Sec | — | $58.9K |
| Frankel Stanley | Dir | $26.1K | — |
| Germano Geno J | Dir | $14.2K | — |
| Brown Melinda | Dir | $6,864 | — |
| Pire Shari Lisa | Dir | — | — |
| Buehler Kevin | Dir | — | — |
Transactions 151
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-05-22 07:31 | 2026-05-20 | DTIL | Buehler Kevin | Dir | M - OptEx | — | +21.0K | 49.1K | +75% | — |
| D | 2026-05-22 07:31 | 2026-05-20 | DTIL | Frankel Stanley | Dir | M - OptEx | — | +21.0K | 40.5K | +108% | — |
| D | 2026-05-22 07:30 | 2026-05-20 | DTIL | Brown Melinda | Dir | M - OptEx | — | +21.0K | 44.3K | +90% | — |
| D | 2026-05-22 07:30 | 2026-05-20 | DTIL | Pire Shari Lisa | Dir | M - OptEx | — | +21.0K | 35.0K | +150% | — |
| D | 2026-05-22 07:30 | 2026-05-20 | DTIL | Germano Geno J | Dir | M - OptEx | — | +21.0K | 44.9K | +88% | — |
| D | 2026-02-19 | 2026-02-17 | DTIL | Amoroso Michael | Pres, CEO, Dir | M - OptEx | $0.00 | +67.8K | 264.0K | +35% | $0 |
| D | 2026-02-19 | 2026-02-18 | DTIL | Amoroso Michael | Pres, CEO, Dir | S - Sale+OE | $3.84 | -20.6K | 243.4K | -8% | -$78.9K |
| D | 2026-02-19 | 2026-02-18 | DTIL | Kelly John Alexander | CFO | S - Sale+OE | $3.84 | -8,149 | 125.9K | -6% | -$31.3K |
| D | 2026-02-19 | 2026-02-17 | DTIL | Kelly John Alexander | CFO | M - OptEx | $0.00 | +27.6K | 134.0K | +26% | $0 |
| D | 2026-02-19 | 2026-02-17 | DTIL | SMITH J. JEFFERSON | Chief Research Off | M - OptEx | $0.00 | +16.7K | 126.9K | +15% | $0 |
| D | 2026-02-19 | 2026-02-18 | DTIL | SMITH J. JEFFERSON | Chief Research Off | S - Sale+OE | $3.84 | -4,925 | 121.9K | -4% | -$18.9K |
| D | 2026-02-19 | 2026-02-17 | DTIL | Scimeca Dario | GC, Sec | M - OptEx | $0.00 | +16.7K | 61.4K | +37% | $0 |
| D | 2026-02-19 | 2026-02-18 | DTIL | Scimeca Dario | GC, Sec | S - Sale+OE | $3.84 | -4,925 | 56.5K | -8% | -$18.9K |
| DM | 2026-01-22 | 2026-01-20+ | DTIL | SMITH J. JEFFERSON | Chief Research Off | M - OptEx | — | +29.2K | 120.4K | +32% | — |
| D | 2026-01-22 | 2026-01-21 | DTIL | SMITH J. JEFFERSON | Chief Research Off | S - Sale+OE | $4.03 | -10.2K | 110.2K | -8% | -$41.1K |
| DM | 2026-01-22 | 2026-01-20 | DTIL | Scimeca Dario | GC, Sec | M - OptEx | $0.00 | +25.3K | 53.6K | +90% | $0 |
| D | 2026-01-22 | 2026-01-21 | DTIL | Scimeca Dario | GC, Sec | S - Sale+OE | $4.03 | -8,854 | 44.7K | -17% | -$35.7K |
| D | 2026-01-22 | 2026-01-22 | DTIL | Amoroso Michael | Pres, CEO, Dir | S - Sale+OE | $4.17 | -34.8K | 196.2K | -15% | -$145.1K |
| DM | 2026-01-22 | 2026-01-20 | DTIL | Amoroso Michael | Pres, CEO, Dir | M - OptEx | — | +115.4K | 231.0K | +100% | — |
| DM | 2026-01-22 | 2026-01-20 | DTIL | Kelly John Alexander | CFO | M - OptEx | — | +44.4K | 81.2K | +120% | — |
| D | 2026-01-22 | 2026-01-21 | DTIL | Kelly John Alexander | CFO | S - Sale+OE | $4.03 | -15.2K | 106.4K | -13% | -$61.3K |
| 2025-12-17 | 2025-12-16 | DTIL | Frankel Stanley | Dir | P - Purchase | $4.70 | +2,700 | 19.5K | +16% | +$12.7K | |
| 2025-12-17 | 2025-12-16 | DTIL | Germano Geno J | Dir | P - Purchase | $4.72 | +3,000 | 23.9K | +14% | +$14.2K | |
| 2025-12-17 | 2025-12-15 | DTIL | Brown Melinda | Dir | P - Purchase | $4.97 | +1,381 | 23.3K | +6% | +$6,864 | |
| D | 2025-11-04 | 2025-11-02 | DTIL | Kelly John Alexander | CFO | M - OptEx | $0.00 | +3,605 | 78.6K | +5% | $0 |
| D | 2025-11-04 | 2025-11-03 | DTIL | Kelly John Alexander | CFO | S - Sale+OE | $6.49 | -1,303 | 77.3K | -2% | -$8,456 |
| D | 2025-11-04 | 2025-11-03 | DTIL | Amoroso Michael | Pres, CEO, Dir | S - Sale+OE | $6.49 | -3,409 | 115.6K | -3% | -$22.1K |
| D | 2025-11-04 | 2025-11-02 | DTIL | Amoroso Michael | Pres, CEO, Dir | M - OptEx | $0.00 | +9,444 | 119.0K | +9% | $0 |
| D | 2025-11-04 | 2025-11-03 | DTIL | Scimeca Dario | GC, Sec | S - Sale+OE | $6.49 | -665 | 28.3K | -2% | -$4,316 |
| D | 2025-11-04 | 2025-11-02 | DTIL | Scimeca Dario | GC, Sec | M - OptEx | $0.00 | +1,835 | 28.9K | +7% | $0 |
| 2025-09-30 | 2025-09-26 | DTIL | Frankel Stanley | Dir | P - Purchase | $4.97 | +2,700 | 16.8K | +19% | +$13.4K | |
| 2025-09-24 | 2025-09-22 | DTIL | Brown Melinda | Dir | P - Purchase | $4.89 | +1,400 | 22.0K | +7% | +$6,846 | |
| 2025-07-08 | 2025-07-03 | DTIL | Kelly John Alexander | CFO | S - Sale | $4.26 | -14.8K | 73.5K | -17% | -$63.2K | |
| 2025-06-27 | 2025-06-25 | DTIL | Brown Melinda | Dir | P - Purchase | $4.14 | +1,682 | 20.6K | +9% | +$6,963 | |
| 2025-06-27 | 2025-06-25 | DTIL | Buehler Kevin | Dir | P - Purchase | $4.16 | +5,076 | 28.1K | +22% | +$21.1K | |
| D | 2025-06-04 | 2025-05-27 | DTIL | Frankel Stanley | Dir | M - OptEx | — | +9,826 | 14.1K | +231% | — |
| D | 2025-06-04 | 2025-05-27 | DTIL | Pire Shari Lisa | Dir | M - OptEx | — | +9,826 | 14.0K | +234% | — |
| D | 2025-06-04 | 2025-05-27 | DTIL | Brown Melinda | Dir | M - OptEx | — | +9,826 | 18.9K | +108% | — |
| D | 2025-06-04 | 2025-05-27 | DTIL | Buehler Kevin | Dir | M - OptEx | — | +9,826 | 23.1K | +74% | — |
| D | 2025-06-04 | 2025-05-27 | DTIL | Germano Geno J | Dir | M - OptEx | — | +9,826 | 20.9K | +89% | — |
| 2025-03-28 | 2025-03-26 | DTIL | Buehler Kevin | Dir | P - Purchase | $4.67 | +4,523 | 13.2K | +52% | +$21.1K | |
| 2025-03-28 | 2025-03-26 | DTIL | Brown Melinda | Dir | P - Purchase | $4.75 | +1,839 | 9,057 | +25% | +$8,735 | |
| 2025-03-27 | 2025-03-25 | DTIL | Germano Geno J | Dir | P - Purchase | $5.30 | +3,250 | 11.1K | +42% | +$17.2K | |
| DT | 2025-03-25 | 2025-03-21 | DTIL | Amoroso Michael | Pres, CEO, Dir | M - OptEx | — | +3,417 | 110.5K | +3% | — |
| DT | 2025-03-25 | 2025-03-24 | DTIL | Amoroso Michael | Pres, CEO, Dir | S - Sale+OE | $5.56 | -964 | 109.5K | -0.9% | -$5,360 |
| DT | 2025-03-05 | 2025-03-04 | DTIL | Scimeca Dario | GC, Sec | S - Sale+OE | $4.91 | -272 | 25.0K | -1% | -$1,336 |
| DT | 2025-03-05 | 2025-03-03 | DTIL | Scimeca Dario | GC, Sec | M - OptEx | — | +919 | 25.3K | +4% | — |
| DT | 2025-03-05 | 2025-03-03 | DTIL | SMITH J. JEFFERSON | Chief Research Off | M - OptEx | — | +519 | 88.0K | +0.6% | — |
| DT | 2025-03-05 | 2025-03-04 | DTIL | SMITH J. JEFFERSON | Chief Research Off | S - Sale+OE | $4.91 | -154 | 87.8K | -0.2% | -$756.14 |
| D | 2025-03-05 | 2025-03-03 | DTIL | Kelly John Alexander | CFO | M - OptEx | — | +1,702 | 86.3K | +2% | — |
| DT | 2025-01-22 | 2025-01-20 | DTIL | Amoroso Michael | Pres, CEO, Dir | M - OptEx | — | +115.4K | 143.9K | +404% | — |
| DT | 2025-01-22 | 2025-01-21 | DTIL | Amoroso Michael | Pres, CEO, Dir | S - Sale+OE | $4.67 | -36.8K | 107.1K | -26% | -$172.0K |
| DT | 2025-01-22 | 2025-01-20 | DTIL | SMITH J. JEFFERSON | Chief Research Off | M - OptEx | — | +29.2K | 97.7K | +43% | — |
| DT | 2025-01-22 | 2025-01-22 | DTIL | SMITH J. JEFFERSON | Chief Research Off | S - Sale+OE | $4.79 | -10.3K | 87.4K | -11% | -$49.3K |
| DT | 2025-01-22 | 2025-01-20 | DTIL | Scimeca Dario | GC, Sec | M - OptEx | — | +25.3K | 33.3K | +318% | — |
| DT | 2025-01-22 | 2025-01-22 | DTIL | Scimeca Dario | GC, Sec | S - Sale+OE | $4.79 | -8,928 | 24.4K | -27% | -$42.8K |
| D | 2025-01-22 | 2025-01-20 | DTIL | Kelly John Alexander | CFO | M - OptEx | — | +44.4K | 84.6K | +110% | — |
| 2025-01-02 | 2024-12-30 | DTIL | Germano Geno J | Dir | P - Purchase | $4.49 | +3,605 | 7,807 | +86% | +$16.2K | |
| 2024-12-31 | 2024-12-27 | DTIL | Kelly John Alexander | CFO | P - Purchase | $4.75 | +2,113 | 40.2K | +6% | +$10.0K | |
| 2024-12-31 | 2024-12-27 | DTIL | Buehler Kevin | Dir | P - Purchase | $4.88 | +4,320 | 8,712 | +98% | +$21.1K | |
| 2024-12-30 | 2024-12-26 | DTIL | Brown Melinda | Dir | P - Purchase | $4.55 | +3,016 | 7,218 | +72% | +$13.7K | |
| 2024-11-21 | 2024-11-21 | DTIL | Kelly John Alexander | CFO | P - Purchase | $6.76 | +3,000 | 38.1K | +9% | +$20.3K | |
| D | 2024-11-05 | 2024-11-02 | DTIL | Amoroso Michael | Pres, CEO, Dir | M - OptEx | — | +9,443 | 31.5K | +43% | — |
| D | 2024-11-05 | 2024-11-04 | DTIL | Amoroso Michael | Pres, CEO, Dir | S - Sale+OE | $8.19 | -3,012 | 28.5K | -10% | -$24.7K |
| D | 2024-11-05 | 2024-11-02 | DTIL | Kelly John Alexander | CFO | M - OptEx | — | +3,605 | 35.1K | +11% | — |
| DT | 2024-11-05 | 2024-11-02 | DTIL | Scimeca Dario | GC, Sec | M - OptEx | $0.00 | +1,836 | 8,557 | +27% | $0 |
| DT | 2024-11-05 | 2024-11-04 | DTIL | Scimeca Dario | GC, Sec | S - Sale+OE | $8.19 | -588 | 7,969 | -7% | -$4,816 |
| D | 2024-06-11 | 2024-06-07 | DTIL | Kelly John Alexander | CFO | M - OptEx | — | +454 | 31.5K | +1% | — |
| D | 2024-06-11 | 2024-06-07 | DTIL | SMITH J. JEFFERSON | Chief Research Off | M - OptEx | — | +163 | 68.6K | +0.2% | — |
| D | 2024-06-11 | 2024-06-10 | DTIL | SMITH J. JEFFERSON | Chief Research Off | S - Sale+OE | $11.79 | -50 | 68.6K | -0.1% | -$589.50 |
| DT | 2024-06-11 | 2024-06-07 | DTIL | Scimeca Dario | GC, Sec | M - OptEx | $0.00 | +301 | 6,814 | +5% | $0 |
| DT | 2024-06-11 | 2024-06-10 | DTIL | Scimeca Dario | GC, Sec | S - Sale+OE | $11.79 | -93 | 6,721 | -1% | -$1,096 |
| 2024-05-08 | 2024-05-08 | DTIL | Scimeca Dario | GC, Sec | A - Grant | $12.00 | +833 | 6,513 | +15% | +$9,996 | |
| 2024-05-08 | 2024-05-08 | DTIL | Amoroso Michael | Pres, CEO, Dir | A - Grant | $12.00 | +8,334 | 22.1K | +61% | +$100.0K | |
| 2024-05-08 | 2024-05-08 | DTIL | SMITH J. JEFFERSON | Chief Research Off | A - Grant | $12.00 | +833 | 68.4K | +1% | +$9,996 | |
| 2024-05-08 | 2024-05-08 | DTIL | Kelly John Alexander | CFO | A - Grant | $12.00 | +8,334 | 31.0K | +37% | +$100.0K | |
| D | 2024-05-07 | 2024-05-04 | DTIL | Pire Shari Lisa | Dir | M - OptEx | — | +4,202 | 4,202 | New | — |
| D | 2024-05-07 | 2024-05-04 | DTIL | Germano Geno J | Dir | M - OptEx | — | +4,202 | 4,202 | New | — |
| D | 2024-05-07 | 2024-05-04 | DTIL | Frankel Stanley | Dir | M - OptEx | — | +4,202 | 4,252 | +8,404% | — |
| D | 2024-05-07 | 2024-05-04 | DTIL | Brown Melinda | Dir | M - OptEx | — | +4,202 | 4,202 | New | — |
| D | 2024-05-07 | 2024-05-04 | DTIL | Buehler Kevin | Dir | M - OptEx | — | +4,202 | 4,392 | +2,212% | — |
| D | 2024-05-07 | 2024-05-04 | DTIL | Wadsworth Samuel C. | Dir | M - OptEx | — | +4,202 | 4,202 | New | — |
| D | 2024-05-03 | 2024-02-29 | DTIL | Kelly John Alexander | CFO | A - Grant | $18.50 | +506 | 21.0K | +2% | +$9,361 |
| D | 2024-05-03 | 2024-05-01 | DTIL | Kelly John Alexander | CFO | M - OptEx | — | +1,702 | 22.7K | +8% | — |
| D | 2024-05-03 | 2024-05-02 | DTIL | Amoroso Michael | Pres, CEO, Dir | S - Sale+OE | $10.32 | -1,526 | 13.8K | -10% | -$15.7K |
| D | 2024-05-03 | 2024-05-01 | DTIL | Amoroso Michael | Pres, CEO, Dir | M - OptEx | — | +3,417 | 15.3K | +29% | — |
| D | 2024-05-03 | 2024-05-02 | DTIL | SMITH J. JEFFERSON | Chief Research Off | S - Sale+OE | $10.32 | -154 | 67.6K | -0.2% | -$1,589 |
| D | 2024-05-03 | 2024-02-29 | DTIL | SMITH J. JEFFERSON | Chief Research Off | A - Grant | $12.42 | +1,006 | 67.2K | +2% | +$12.5K |
| D | 2024-05-03 | 2024-05-01 | DTIL | SMITH J. JEFFERSON | Chief Research Off | M - OptEx | — | +519 | 67.8K | +0.8% | — |
| D | 2024-05-03 | 2024-05-02 | DTIL | List Alan | Chief Medical Off | S - Sale+OE | $10.32 | -290 | 4,488 | -6% | -$2,993 |
| D | 2024-05-03 | 2024-05-01 | DTIL | List Alan | Chief Medical Off | M - OptEx | — | +982 | 4,778 | +26% | — |
| DT | 2024-05-03 | 2024-05-02 | DTIL | Scimeca Dario | GC, Sec | S - Sale+OE | $10.32 | -272 | 5,680 | -5% | -$2,807 |
| DT | 2024-05-03 | 2024-05-01 | DTIL | Scimeca Dario | GC, Sec | M - OptEx | — | +918 | 5,952 | +18% | — |
| D | 2024-04-30 | 2024-04-30 | DTIL | List Alan | Chief Medical Off | S - Sale+OE | $10.03 | -238 | 3,796 | -6% | -$2,387 |
| D | 2024-04-30 | 2024-04-26 | DTIL | List Alan | Chief Medical Off | M - OptEx | — | +868 | 4,034 | +27% | — |
| D | 2024-01-23 | 2024-01-22 | DTIL | List Alan | Chief Medical Off | S - Sale+OE | $0.36 | -21.5K | 95.0K | -18% | -$7,749 |
| D | 2024-01-23 | 2024-01-20 | DTIL | List Alan | Chief Medical Off | M - OptEx | — | +60.0K | 116.5K | +106% | — |
| D | 2024-01-23 | 2024-01-23 | DTIL | SMITH J. JEFFERSON | Chief Research Off | S - Sale+OE | $0.37 | -28.0K | 1.99M | -1% | -$10.4K |
| D | 2024-01-23 | 2024-01-20 | DTIL | SMITH J. JEFFERSON | Chief Research Off | M - OptEx | — | +75.0K | 2.02M | +4% | — |
| D | 2024-01-23 | 2024-01-20 | DTIL | Scimeca Dario | GC, Sec | M - OptEx | — | +59.3K | 172.3K | +53% | — |
Purchase Sale Sale after option exercise All abbreviations